about
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.Promise and pitfalls of heavy-particle therapy.Houttuynia cordata Thunb extract modulates G0/G1 arrest and Fas/CD95-mediated death receptor apoptotic cell death in human lung cancer A549 cellsCurrent concepts in clinical radiation oncology.Particle therapy for noncancer diseases.Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastaInterleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer.Biology-guided adaptive radiotherapy (BiGART)--more than a vision?A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer.Image guided therapy - do we get the picture?
P2860
Q30570350-C7CE2D9E-2996-498F-AD82-A23BDA2E7924Q34124263-1B7F42D2-E0D1-45A0-93ED-DC3FFE5F357DQ36722711-C058479E-E253-4BD3-9740-A2AB7860B59AQ37603804-7E4EEF5E-00A1-4907-B8FC-17448038A295Q38000635-4E4BA3E2-479F-4C5E-952A-328C056FF92CQ38226816-4A21323F-28E3-4D66-9AC7-FC92855E2ABBQ38227883-EBC76913-218D-48FE-B45D-5DCEAD57C861Q38763620-C4A476F5-7529-4B64-A7EF-D335F04B7FD6Q41431618-5B3E0B93-CBC2-4584-9206-62C3B79B22DAQ44257627-9388A517-8860-4E84-B1E3-9782080D5531Q44848976-41CC5B3D-8071-4EFD-8FC6-BCAD0F442023Q45122044-EAF6D7CF-15D8-464F-8376-62EEAFFB39DCQ51713838-94B3FD15-2B68-4E17-8CF9-E50E302A42F0Q54521800-B4400753-1E5D-4DBF-8460-82ACAAD1B94A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Status of particle therapy for lung cancer.
@en
Status of particle therapy for lung cancer.
@nl
type
label
Status of particle therapy for lung cancer.
@en
Status of particle therapy for lung cancer.
@nl
prefLabel
Status of particle therapy for lung cancer.
@en
Status of particle therapy for lung cancer.
@nl
P2093
P2860
P1433
P1476
Status of particle therapy for lung cancer.
@en
P2093
James D Cox
Steven H Lin
Zhongxing Liao
P2860
P304
P356
10.3109/0284186X.2011.590148
P577
2011-08-01T00:00:00Z